The Daily PulseHealth• Updated
New price caps on cancer drugs follow Supreme Court questions
Reported by Abhishek Tiwari (Copy Editor) · The Hindu - Health ·
Confirmed by a second source: Bing News - Health (India)
Photo: Wikimedia CommonsUPDATE - follow-up to Who decides the cost of medicines in India?: India's Supreme Court questioned the large gap between medicine supply prices and retail prices in September 2026. The court pointed out an example where a cancer medicine supplied to a retailer for ₹2,700 had a maximum retail price of ₹27,000. Following this, the National Pharmaceutical Pricing Authority announced a 30% cap on trade margins for 137 anti-cancer drugs on October 17. This rule takes effect from November 9 and aims to lower costs for patients.
Context
India's history with statutory drug price controls dates back to the Defence of India Act during the 1962 Sino-Indian War. Government bodies continue to monitor medicine costs to balance affordability and market supply for patients.
What changed since yesterday
- Supreme Court Questions Drug Price Gap as India Caps Cancer Medicine Margins
Latest
New price caps on cancer drugs follow Supreme Court questions
ExplainerWhy this matters
What Happened
The Supreme Court questioned the massive price gap between what retailers pay for medicines and what patients ultimately pay, leading the National Pharmaceutical Pricing Authority to cap trade margins on 137 anti-cancer drugs at 30%.
Why It Matters
High retail prices for essential medicines like cancer treatments place a heavy financial burden on patients and their families. Price caps help make life-saving drugs more affordable and bridge the gap between manufacturing costs and final retail prices.
What Happens Next
The new 30% trade margin cap takes effect on November 9, and authorities will monitor how effectively it reduces final prices for patients across retail stores.
More in Health
HealthUnconfirmed — Reported by one source so farWorth knowing
Global Study Shows Women Face Higher Rates of Pain Than Men.
Reported by Kavya Rao (Senior Writer) · The Hindu - Health ·
